Literature DB >> 14742275

Beta-secretase activity increases with aging in human, monkey, and mouse brain.

Hiroaki Fukumoto1, Douglas L Rosene, Mark B Moss, Susan Raju, Bradley T Hyman, Michael C Irizarry.   

Abstract

Amyloid beta protein (A beta) accumulates in the brains of aging humans, amyloid precursor protein (APP) transgenic mouse lines, and rhesus monkeys. We tested the hypothesis that aging was associated with increased activity of the beta-site amyloid precursor protein cleaving enzyme (beta-secretase, BACE) in brain. We evaluated BACE activity, BACE protein, and formic acid-extractable A beta levels in cohorts of young (4 months old) and old (14 to 18 months old) nontransgenic mice (n = 16) and Tg2576 APP transgenic mice (n = 17), young (4.4 to 12.7 years old) and old (20.9 to 30.4 years old) rhesus monkeys (n = 17), and a wide age range (18 to 92 years old) of nondemented human brains (n = 25). Aging was associated with increased brain A beta levels in each cohort. Furthermore BACE activity increased significantly with age in mouse, monkey, and human brains, independent of brain region. BACE protein levels, however, were unchanged with age. BACE activity correlated with formic acid-extractable A beta levels in transgenic mouse, nontransgenic mouse, and human cortex, but not in monkey brain. These data suggest that an age-related increase of BACE activity contributes to the increased production and accumulation of brain A beta, and potentially predisposes to Alzheimer's disease in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742275      PMCID: PMC1602259          DOI: 10.1016/s0002-9440(10)63159-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

Authors:  Y Luo; B Bolon; S Kahn; B D Bennett; S Babu-Khan; P Denis; W Fan; H Kha; J Zhang; Y Gong; L Martin; J C Louis; Q Yan; W G Richards; M Citron; R Vassar
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

2.  Phosphorylation regulates intracellular trafficking of beta-secretase.

Authors:  J Walter; R Fluhrer; B Hartung; M Willem; C Kaether; A Capell; S Lammich; G Multhaup; C Haass
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

3.  Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

Authors:  B T Hyman; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  1997-10       Impact factor: 3.685

4.  Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production.

Authors:  S Benjannet; A Elagoz; L Wickham; M Mamarbachi; J S Munzer; A Basak; C Lazure; J A Cromlish; S Sisodia; F Checler; M Chrétien; N G Seidah
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

5.  Maturation and pro-peptide cleavage of beta-secretase.

Authors:  A Capell; H Steiner; M Willem; H Kaiser; C Meyer; J Walter; S Lammich; G Multhaup; C Haass
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

6.  The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain.

Authors:  X P Shi; E Chen; K C Yin; S Na; V M Garsky; M T Lai; Y M Li; M Platchek; R B Register; M K Sardana; M J Tang; J Thiebeau; T Wood; J A Shafer; S J Gardell
Journal:  J Biol Chem       Date:  2001-03-30       Impact factor: 5.157

7.  beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging.

Authors:  M C Irizarry; J J Locascio; B T Hyman
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

8.  Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer's disease beta-secretase.

Authors:  J T Huse; D S Pijak; G J Leslie; V M Lee; R W Doms
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

9.  Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates.

Authors:  J Ermolieff; J A Loy; G Koelsch; J Tang
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

10.  Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes.

Authors:  Ayae Kinoshita; Hiroaki Fukumoto; Tejal Shah; Christa M Whelan; Michael C Irizarry; Bradley T Hyman
Journal:  J Cell Sci       Date:  2003-06-26       Impact factor: 5.285

View more
  107 in total

1.  BACE1 gene promoter single-nucleotide polymorphisms in Alzheimer's disease.

Authors:  Weihui Zhou; Fang Cai; Yu Li; George S Yang; Kathleen D O'Connor; Robert A Holt; Weihong Song
Journal:  J Mol Neurosci       Date:  2010-05-09       Impact factor: 3.444

2.  BACE2 expression increases in human neurodegenerative disease.

Authors:  Christopher J Holler; Robin L Webb; Ashley L Laux; Tina L Beckett; Dana M Niedowicz; Rachel R Ahmed; Yinxing Liu; Christopher R Simmons; Amy L S Dowling; Angela Spinelli; Moshe Khurgel; Steven Estus; Elizabeth Head; Louis B Hersh; M Paul Murphy
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

3.  Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines.

Authors:  Viorela Pop; Elizabeth Head; Nicole C Berchtold; Charles G Glabe; Christa M Studzinski; Adam M Weidner; M Paul Murphy; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2010-04-30       Impact factor: 4.673

4.  Widespread distribution of reticulon-3 in various neurodegenerative diseases.

Authors:  Jonathon E Heath; Sandra L Siedlak; Xiongwei Zhu; Hyoung-Gon Lee; Akanksha Thakur; Riqiang Yan; George Perry; Mark A Smith; Rudy J Castellani
Journal:  Neuropathology       Date:  2010-12       Impact factor: 1.906

5.  A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease.

Authors:  Hiroaki Fukumoto; Hideki Takahashi; Naoki Tarui; Junji Matsui; Taisuke Tomita; Mitsuhiro Hirode; Masumi Sagayama; Ryouta Maeda; Makiko Kawamoto; Kazuko Hirai; Jun Terauchi; Yasufumi Sakura; Mitsuru Kakihana; Kaneyoshi Kato; Takeshi Iwatsubo; Masaomi Miyamoto
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

6.  miR-186 is decreased in aged brain and suppresses BACE1 expression.

Authors:  Jaekwang Kim; Hyejin Yoon; Dah-Eun Chung; Jennifer L Brown; Krystal C Belmonte; Jungsu Kim
Journal:  J Neurochem       Date:  2016-03-30       Impact factor: 5.372

7.  Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease.

Authors:  S Schäfer; O Wirths; G Multhaup; T A Bayer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-31       Impact factor: 3.575

8.  Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of β-Secretase 1 (BACE-1) in the Brain.

Authors:  Xike Qin; Yunling Wang; Hemant K Paudel
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

9.  Design and characterization of a new cell-permeant inhibitor of the beta-secretase BACE1.

Authors:  Solveig Lefranc-Jullien; Vincent Lisowski; Jean-François Hernandez; Jean Martinez; Frédéric Checler
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 10.  Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.

Authors:  Walter J Lukiw; Miguel Pappolla; Ricardo Palacios Pelaez; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.